Welcome to John Ransom's Stocks In The News, where the headline meets the trendline.
Stocks in the News is produced by Ransom Notes Radio and Goodfellow, LLC. Crista Huff manages Goodfellow LLC, a website that recommends outperforming stocks using fundamental and technical analysis.
Stock number one is:
Talks of a $13 billion acquisition of Actavis Inc. by Valeant Pharmaceuticals are currently on hold as both sides spar over pricing.
Valeant is a rapidly growing specialty drugmaker, in the areas of dermatology, neurology and ophthalmology. Valeant’s earnings are expected to grow 24% this year, and the PE is 13.6.
Actavis develops and markets generic and branded pharmaceutical products. Its earnings are projected to grow 35% this year, then slow dramatically thereafter. The PE is 12.9. Based on earnings growth and chart patterns, …
Our Ransom Note trendline says: BUY VALEANT PHARMACEUTICALS and HOLD ACTAVIS.
Stock number two is:
Get the Market Movements in Advance: William's Edge Webinar for Thursday, March 13th, 2014 | John Ransom
Taxi Publication Threatens To Expose ‘Secretly Gay’ Aldermen If City Doesn’t Ban Ride-Sharing | Nick Sorrentino